News Releases Year: - Any -202020192018201720162015201420132012 Items per page 102550 05/08/20 Summary ToggleClearside Biomedical Announces First Quarter 2020 Financial Results PDF Version 04/28/20 Summary ToggleClearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health PDF Version 04/22/20 Summary ToggleClearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors PDF Version 04/09/20 Summary ToggleClearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians PDF Version 04/08/20 Summary ToggleClearside Biomedical to Present at the Needham Virtual Healthcare Conference PDF Version 03/11/20 Summary ToggleClearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update PDF Version 03/11/20 Summary ToggleClearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer PDF Version 03/11/20 Summary ToggleClearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea PDF Version 02/27/20 Summary ToggleClearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 PDF Version 02/26/20 Summary ToggleClearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020 PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page Last
